Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15)

Avelumab plus weekly paclitaxel demonstrated preliminary evidence of efficacy and tolerability in inoperable angiosarcoma. Given the rarity of angiosarcoma, further multicenter, collaborative, and translational studies are warranted.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2026-01-22
DOI
https://doi.org/10.1016/j.esmoop.2025.106018
Primary Topic
Vascular Tumors and Angiosarcomas
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15)

J. Kim, S.Y. Oh, M.-W. Lee, J.-Y. Hong et al.
ESMO Open
Vascular Tumors and Angiosarcomas
article

Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15)

J. Kim, S.Y. Oh, M.-W. Lee, J.-Y. Hong, H.R. Kim, W.K. Bae, M.J. Kang, M. Kim, S.-A. Im, J. Lee, Y.J. Kim, Y.S. Kim, K. Park
article en

Abstract

Avelumab plus weekly paclitaxel demonstrated preliminary evidence of efficacy and tolerability in inoperable angiosarcoma. Given the rarity of angiosarcoma, further multicenter, collaborative, and translational studies are warranted.

ESMO OpenVol. 11(2)
Ulsan College (KR), Asan Medical Center (KR), Samsung Medical Center (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), University of Ulsan (KR), Gachon University Gil Hospital (KR), Inje University Haeundae Paik Hospital (KR), Hanyang University Seoul Hospital (KR), Chungnam National University Hospital (KR), Chonnam National University Hwasun Hospital (KR), Dong-A University (KR), Sungkyunkwan University (KR)
Dong-A University
Openalex Percentile: Top 80%
Vascular Tumors and Angiosarcomas
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15) — J. Kim, S.Y. Oh, et al. · ESMO Open (2026) | TGRS Research Map | TGRS